News|Articles|February 26, 2025
Advanced LC-MS Technology for Enhanced HCP Detection in Complex Biotherapeutics
Author(s)Samsung Biologics
The identification, characterization, and quantitation of host cell protein (HCP) impurities are a critical challenge in the biopharmaceutical industry. Advanced LC-MS techniques can be integrated into manufacturing workflows to mitigate risks and ensure higher product quality and improved patient safety.
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Trending on Pharmaceutical Technology
1
Standardizing Operations to Meet Global Sustainability and Resilience Goals
2
Takeda’s Sriman Banerjee Discusses Smart Packaging at CPHI Frankfurt 2025
3
PharmTech Weekly News Roundup — Week of October 27, 2025
4
Drug Digest: Strategic Alliances and Technology Integration in the Evolving Biopharma Landscape
5
